Quantcast

NASDAQ Companies

Page: 1 of 66
Exchange:   NASDAQ
Displaying 1-50 of 3276 results Download this list
Name Symbol Market Cap ADR TSO Country IPO Year Subsector
1347 Property Insurance Holdings, Inc.

PIH

$44.59M United States 2014 Property-Casualty Insurers
180 Degree Capital Corp.

TURN

$62.09M United States n/a Finance/Investors Services
1-800 FLOWERS.COM, Inc.

FLWS

$694.71M United States 1999 Other Specialty Stores
1st Constitution Bancorp (NJ)

FCCY

$148.14M United States n/a Savings Institutions
1st Source Corporation

SRCE

$1.3B United States n/a Major Banks
21Vianet Group, Inc.

VNET

$389.79M 59,691,833 China 2011 Computer Software: Programming, Data Processing
2U, Inc.

TWOU

$3.23B United States 2014 Computer Software: Prepackaged Software
51job, Inc.

JOBS

$2.15B 36,793,371 China 2004 Diversified Commercial Services
8point3 Energy Partners LP

CAFD

$1.13B United States 2015 Electric Utilities: Central
8x8 Inc

EGHT

$1.3B United States n/a Telecommunications Equipment
A V Homes, Inc.

AVHI

$385.12M United States n/a Homebuilding
A. Schulman, Inc.

SHLM

$1.08B United States 1972 Major Chemicals
AAON, Inc.

AAON

$1.84B United States n/a Industrial Machinery/Components
ABAXIS, Inc.

ABAX

$1.08B United States 1992 Industrial Machinery/Components
Abeona Therapeutics Inc.

ABEO

$727.36M United States n/a Major Pharmaceuticals
Abeona Therapeutics Inc.

ABEOW

n/a United States n/a Major Pharmaceuticals
Ability Inc.

ABIL

$10.42M Israel 2014 Business Services
ABIOMED, Inc.

ABMD

$8.55B United States n/a Medical/Dental Instruments
Ablynx NV

ABLX

$314.55M 13,144,500 Belgium 2017 Biotechnology: Biological Products (No Diagnostic Substances)
Abraxas Petroleum Corporation

AXAS

$348.37M United States n/a Oil & Gas Production
AC Immune SA

ACIU

$683.07M Switzerland 2016 Major Pharmaceuticals
Acacia Communications, Inc.

ACIA

$1.65B United States 2016 Semiconductors
Acacia Research Corporation

ACTG

$217.6M United States n/a Multi-Sector Companies
Acadia Healthcare Company, Inc.

ACHC

$2.82B United States n/a Medical Specialities
ACADIA Pharmaceuticals Inc.

ACAD

$3.72B United States 2004 Major Pharmaceuticals
Acasti Pharma, Inc.

ACST

$23.68M Canada n/a Major Pharmaceuticals
Accelerate Diagnostics, Inc.

AXDX

$1.59B United States n/a Biotechnology: Laboratory Analytical Instruments
Acceleron Pharma Inc.

XLRN

$1.62B United States 2013 Biotechnology: Biological Products (No Diagnostic Substances)
Access National Corporation

ANCX

$581.68M United States n/a Savings Institutions
Accuray Incorporated

ARAY

$407.01M United States 2007 Medical/Dental Instruments
AcelRx Pharmaceuticals, Inc.

ACRX

$106.97M United States 2011 Major Pharmaceuticals
Acer Therapeutics Inc.

ACER

$91.28M United States n/a Major Pharmaceuticals
Acer Therapeutics Inc.

ACERW

n/a United States n/a Major Pharmaceuticals
Aceto Corporation

ACET

$334.6M United States n/a Other Pharmaceuticals
Achaogen, Inc.

AKAO

$479.47M United States 2014 Major Pharmaceuticals
Achieve Life Sciences, Inc.

ACHV

$15.77M United States n/a Biotechnology: In Vitro & In Vivo Diagnostic Substances
Achillion Pharmaceuticals, Inc.

ACHN

$394.27M United States 2006 Major Pharmaceuticals
ACI Worldwide, Inc.

ACIW

$2.65B United States n/a Computer Software: Prepackaged Software
Aclaris Therapeutics, Inc.

ACRS

$765.93M United States 2015 Major Pharmaceuticals
ACM Research, Inc.

ACMR

$90.07M United States 2017 Industrial Machinery/Components
ACNB Corporation

ACNB

$203.92M United States n/a Major Banks
Acorda Therapeutics, Inc.

ACOR

$953.64M United States 2006 Biotechnology: Biological Products (No Diagnostic Substances)
Active Alts Contrarian ETF

SQZZ

n/a United States n/a n/a
Activision Blizzard, Inc

ATVI

$47.76B United States n/a Computer Software: Prepackaged Software
Actua Corporation

ACTA

$508.83M United States n/a EDP Services
Acxiom Corporation

ACXM

$2.15B United States n/a EDP Services
Adamas Pharmaceuticals, Inc.

ADMS

$807.97M United States 2014 Major Pharmaceuticals
Adamis Pharmaceuticals Corporation

ADMP

$146.9M United States n/a Major Pharmaceuticals
Adaptimmune Therapeutics plc

ADAP

$462.84M 58,438,964 United Kingdom 2015 Biotechnology: Biological Products (No Diagnostic Substances)
Addus HomeCare Corporation

ADUS

$374.54M United States 2009 Medical/Nursing Services
*IPO year information is not available for stocks prior to 1970.